HBK INVESTMENTS L P - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182958. A total of 5 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q2 2021$1,878,000
+32.9%
11,6000.0%0.01%
+16.7%
Q1 2021$1,413,00011,6000.01%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2023
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 225$1,060,0000.10%
GROUP ONE TRADING, L.P. 9,500$447,0000.00%
SIMPLEX TRADING, LLC 278$1,309,0000.00%
JPMORGAN CHASE & CO 31,900$1,447,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CRISPR THERAPEUTICS AG shareholders